Use of tranexamic acid (TXA) reduced the risk of major bleeding in patients undergoing urologic surgery, results from the ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...

A urologist at Raleigh General Hospital has completed her 200th aquablation surgery, marking a milestone for both the ...

Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic diseases, today announced it has received U.S. Food and Drug Administration (FDA ...

Large international study finds nearly half of patients admitted with visible blood in urine receive no imaging, delaying ...

The PAUSE-URO study evaluated the safety of a new protocol for patients using direct oral anticoagulants (DOACs) prior to elective urologic surgery.

Prodeon Medical, a privately held medical device company focused on advancing minimally invasive therapies for urologic ...

The analysis – reported at the European Association of Urology (EAU) annual congress in London, UK – shows that it is "no ...

Johnson & Johnson has revealed early clinical data with a new formulation of its FGFR inhibitor erdafitinib that suggests it ...

Cybersecurity incidents in healthcare don’t just threaten data—they can disrupt clinical operations, delay procedures, and erode trust. When a company ...

Olympus Corporation has launched its VISERA ELITE III surgical imaging platform in the US, developed to improve visualisation ...

A senior faculty member from the Department of Blood Transfusion, Dr Kaur claims her immediate focus will be on strengthening ...